AR033788A1 - Envase primario, uso de un tapon o embolo de caucho que contiene caucho de bromobutilo para sellar el envase primario y procedimiento para la manufactura del envase primario - Google Patents

Envase primario, uso de un tapon o embolo de caucho que contiene caucho de bromobutilo para sellar el envase primario y procedimiento para la manufactura del envase primario

Info

Publication number
AR033788A1
AR033788A1 ARP990104129A AR033788A1 AR 033788 A1 AR033788 A1 AR 033788A1 AR P990104129 A ARP990104129 A AR P990104129A AR 033788 A1 AR033788 A1 AR 033788A1
Authority
AR
Argentina
Prior art keywords
rubber
primary container
primary
seal
procedure
Prior art date
Application number
Other languages
English (en)
Spanish (es)
Original Assignee
Astra Zeneca
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Zeneca filed Critical Astra Zeneca
Publication of AR033788A1 publication Critical patent/AR033788A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/05—Containers specially adapted for medical or pharmaceutical purposes for collecting, storing or administering blood, plasma or medical fluids ; Infusion or perfusion containers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/724—Cyclodextrins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/40—Cyclodextrins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178—Syringes
    • A61M5/31—Details
    • A61M5/3129—Syringe barrels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/05—Containers specially adapted for medical or pharmaceutical purposes for collecting, storing or administering blood, plasma or medical fluids ; Infusion or perfusion containers
    • A61J1/06—Ampoules or carpules
    • A61J1/062—Carpules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/14—Details; Accessories therefor
    • A61J1/1468—Containers characterised by specific material properties

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Anesthesiology (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Inorganic Chemistry (AREA)
  • Vascular Medicine (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
  • Detergent Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
ARP990104129 1998-09-01 1999-08-18 Envase primario, uso de un tapon o embolo de caucho que contiene caucho de bromobutilo para sellar el envase primario y procedimiento para la manufactura del envase primario AR033788A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9802938A SE9802938D0 (sv) 1998-09-01 1998-09-01 Improved stability for injection solutions

Publications (1)

Publication Number Publication Date
AR033788A1 true AR033788A1 (es) 2004-01-07

Family

ID=20412436

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP990104129 AR033788A1 (es) 1998-09-01 1999-08-18 Envase primario, uso de un tapon o embolo de caucho que contiene caucho de bromobutilo para sellar el envase primario y procedimiento para la manufactura del envase primario

Country Status (33)

Country Link
US (4) US6576245B1 (enExample)
EP (1) EP1109526B1 (enExample)
JP (1) JP2002523184A (enExample)
KR (1) KR100614162B1 (enExample)
CN (1) CN1230141C (enExample)
AR (1) AR033788A1 (enExample)
AT (1) ATE262882T1 (enExample)
AU (1) AU754447C (enExample)
BR (1) BR9913261A (enExample)
CA (1) CA2340238C (enExample)
CZ (1) CZ2001743A3 (enExample)
DE (1) DE69916082T2 (enExample)
DK (1) DK1109526T3 (enExample)
EE (1) EE04768B1 (enExample)
ES (1) ES2217808T3 (enExample)
HU (1) HUP0104161A3 (enExample)
ID (1) ID28015A (enExample)
IL (2) IL141333A0 (enExample)
IS (1) IS2230B (enExample)
MY (1) MY120822A (enExample)
NO (1) NO322292B1 (enExample)
NZ (1) NZ509985A (enExample)
PL (1) PL195244B1 (enExample)
PT (1) PT1109526E (enExample)
RU (1) RU2224499C2 (enExample)
SA (1) SA99200573B1 (enExample)
SE (1) SE9802938D0 (enExample)
SK (1) SK285474B6 (enExample)
TR (1) TR200100679T2 (enExample)
TW (1) TWI228987B (enExample)
UA (1) UA73282C2 (enExample)
WO (1) WO2000012043A1 (enExample)
ZA (1) ZA200101590B (enExample)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9802938D0 (sv) * 1998-09-01 1998-09-01 Astra Ab Improved stability for injection solutions
US6462021B1 (en) 2000-11-06 2002-10-08 Astrazeneca Ab Use of low molecular weight thrombin inhibitor
AR035216A1 (es) * 2000-12-01 2004-05-05 Astrazeneca Ab Derivados de acido mandelico ,derivados farmaceuticamente aceptables, uso de estos derivados para la fabricacion de medicamentos, metodos de tratamiento ,procesos para la preparacion de estos derivados, y compuestos intermediarios
US7129233B2 (en) * 2000-12-01 2006-10-31 Astrazeneca Ab Mandelic acid derivatives and their use as thrombin inhibitors
AR034517A1 (es) * 2001-06-21 2004-02-25 Astrazeneca Ab Formulacion farmaceutica
US6802828B2 (en) * 2001-11-23 2004-10-12 Duoject Medical Systems, Inc. System for filling and assembling pharmaceutical delivery devices
SE0201659D0 (sv) * 2002-05-31 2002-05-31 Astrazeneca Ab Modified release pharmaceutical formulation
SE0201661D0 (sv) * 2002-05-31 2002-05-31 Astrazeneca Ab New salts
PT1569912E (pt) 2002-12-03 2015-09-15 Pharmacyclics Llc Derivados 2-(2-hidroxibifenil-3-il)-1h-benzoimidazole-5- carboxamidina como inibidores do fator viia
AU2004206842A1 (en) * 2003-01-14 2004-08-05 Teva Pharmaceutical Industries, Ltd. Parenteral formulations of peptides for the treatment of systemic lupus erythematosus
KR100505557B1 (ko) * 2003-02-10 2005-08-03 조을룡 약병마개 제조용 고무 조성물
US7781424B2 (en) * 2003-05-27 2010-08-24 Astrazeneca Ab Modified release pharmaceutical formulation
US8476010B2 (en) 2003-07-10 2013-07-02 App Pharmaceuticals Llc Propofol formulations with non-reactive container closures
US7524354B2 (en) * 2005-07-07 2009-04-28 Research Foundation Of State University Of New York Controlled synthesis of highly monodispersed gold nanoparticles
US20070166187A1 (en) * 2006-01-18 2007-07-19 Song Jing F Stabilization of paricalcitol using chlorobutyl or chlorinated butyl stoppers
TW200827336A (en) * 2006-12-06 2008-07-01 Astrazeneca Ab New crystalline forms
US20090061000A1 (en) * 2007-08-31 2009-03-05 Astrazeneca Ab Pharmaceutical formulation use 030
US8939943B2 (en) 2011-01-26 2015-01-27 Kaleo, Inc. Medicament delivery device for administration of opioid antagonists including formulations for naloxone
US8627816B2 (en) * 2011-02-28 2014-01-14 Intelliject, Inc. Medicament delivery device for administration of opioid antagonists including formulations for naloxone
JP6144264B2 (ja) * 2011-09-27 2017-06-07 ベクトン ディキンソン フランス 医療用注射装置においてプラズマ処理したシリコーンオイルのコーティングとしての使用
US9517307B2 (en) 2014-07-18 2016-12-13 Kaleo, Inc. Devices and methods for delivering opioid antagonists including formulations for naloxone

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4381779A (en) 1981-07-16 1983-05-03 Sterling Drug Inc. Deformable slidable piston to provide self-aspiration in hypodermic cartridge ampoules
ATE84205T1 (de) 1989-03-28 1993-01-15 Duphar Int Res Vorgefuellte injektionsvorrichtung mit einem fass, das mit einer fluessigen diazepam-formulierung gefuellt ist.
US5219328A (en) * 1990-01-03 1993-06-15 Cryolife, Inc. Fibrin sealant delivery method
SE9103612D0 (sv) 1991-12-04 1991-12-04 Astra Ab New peptide derivatives
SE9301916D0 (sv) 1993-06-03 1993-06-03 Ab Astra New peptides derivatives
SE9402332D0 (sv) * 1994-07-01 1994-07-01 Pharmacia Ab Igf-1
SE9501472D0 (sv) 1995-04-21 1995-04-21 Pharmacia Ab Truncated IGF-I
SA96170106A (ar) 1995-07-06 2005-12-03 أسترا أكتيبولاج مشتقات حامض أميني جديدة
AR005245A1 (es) 1995-12-21 1999-04-28 Astrazeneca Ab Prodrogas de inhibidores de trombina, una formulación farmaceutica que las comprende, el uso de dichas prodrogas para la manufactura de un medicamento y un procedimiento para su preparacion
SE9601556D0 (sv) * 1996-04-24 1996-04-24 Astra Ab New pharmaceutical formulation of a thrombin inhibitor for parenteral use
SE9802938D0 (sv) 1998-09-01 1998-09-01 Astra Ab Improved stability for injection solutions

Also Published As

Publication number Publication date
US6576245B1 (en) 2003-06-10
RU2224499C2 (ru) 2004-02-27
PT1109526E (pt) 2004-07-30
SK2822001A3 (en) 2001-08-06
WO2000012043A1 (en) 2000-03-09
IL141333A (en) 2006-07-05
US20040235731A1 (en) 2004-11-25
CN1314804A (zh) 2001-09-26
EE04768B1 (et) 2007-02-15
HK1035482A1 (en) 2001-11-30
KR20010073070A (ko) 2001-07-31
US20060233778A1 (en) 2006-10-19
NO322292B1 (no) 2006-09-11
BR9913261A (pt) 2001-05-22
TR200100679T2 (tr) 2001-07-23
DK1109526T3 (da) 2004-07-05
EP1109526B1 (en) 2004-03-31
NO20011032L (no) 2001-04-30
ZA200101590B (en) 2002-05-27
AU5890399A (en) 2000-03-21
PL346471A1 (en) 2002-02-11
JP2002523184A (ja) 2002-07-30
AU754447C (en) 2006-10-19
IL141333A0 (en) 2002-03-10
US6998136B2 (en) 2006-02-14
SK285474B6 (sk) 2007-02-01
ATE262882T1 (de) 2004-04-15
SE9802938D0 (sv) 1998-09-01
DE69916082T2 (de) 2004-10-21
CA2340238C (en) 2009-01-06
MY120822A (en) 2005-11-30
HUP0104161A3 (en) 2002-08-28
HUP0104161A2 (hu) 2002-04-29
PL195244B1 (pl) 2007-08-31
UA73282C2 (en) 2005-07-15
EP1109526A1 (en) 2001-06-27
AU754447B2 (en) 2002-11-14
SA99200573B1 (ar) 2006-09-20
ES2217808T3 (es) 2004-11-01
EE200100131A (et) 2002-06-17
ID28015A (id) 2001-05-03
SA99200573A (ar) 2005-12-03
NO20011032D0 (no) 2001-02-28
IS2230B (is) 2007-04-15
DE69916082D1 (de) 2004-05-06
US6660279B2 (en) 2003-12-09
KR100614162B1 (ko) 2006-08-25
US20030190310A1 (en) 2003-10-09
CN1230141C (zh) 2005-12-07
TWI228987B (en) 2005-03-11
CZ2001743A3 (cs) 2002-01-16
CA2340238A1 (en) 2000-03-09
IS5845A (is) 2001-02-15
NZ509985A (en) 2002-12-20

Similar Documents

Publication Publication Date Title
AR033788A1 (es) Envase primario, uso de un tapon o embolo de caucho que contiene caucho de bromobutilo para sellar el envase primario y procedimiento para la manufactura del envase primario
AR246185A1 (es) Un dispositivo administrador y su combinacion con una cubierta de alojamiento para un recipiente de una sustancia a administrar.
CO5271681A1 (es) Caperuza de cierre y recipiente en forma de cartucho de dos camaras para nebulizador destinado a la produccion de aerosoles y formulaciones almacenables muy concentradas de sustancias activas
BR0313498A (pt) Sistema de fecho para um frasco, frasco farmacêutico, métodos para fechar um frasco e para encher um frasco farmacêutico, fecho de frasco, e, suporte para um frasco
MX9303240A (es) Tapon doble para botella parenteral.
ES2152086T3 (es) Procedimiento para llenar una capsula con un medicamento y articulo producido de esta manera.
ES2122321T3 (es) Dispositivo de jeringa para la mezcla de dos compuestos.
ES2178388T3 (es) Recipientes dispensadores presurizados.
MY129847A (en) Medicament vial having a heat-sealable cap, and apparatus and method for filling the vial
ES2090516T3 (es) Recipiente y sistema de dispensacion de un medicamento.
AR017809A1 (es) Un dispositivo conector, para establecer una comunicacion fluida entre un primer y segundo contenedor, utilizados en procesos de reconstitucion de drogas.
ES2147298T3 (es) Recipiente con caperuza de cierre y procedimiento para el llenado de los recipientes con liquidos sin burbujas de gas.
AR029364A2 (es) Envase para reconstituir un liquido para uso medicinal, y uso del envase
MXPA05008098A (es) Frasco de medicamento que tiene una tapa que se puede sellar con calor y aparato y metodo de llenado del frasco.
BRPI0409936A (pt) uso de um material, recipiente pelo menos parcialmente cheio, e, kit médico
AR029254A1 (es) Un sistema de envase y un cierre que comprende dicho envase
ATE244029T1 (de) Pharmazeutische ampulle
ES2148512T3 (es) Complejos de inclusion multicomponentes de alta solubilidad que constan de una sustancia farmaceutica acidica, una ciclodextrina y una base.
AR012968A1 (es) Envase del tipo para contener separadamente un primer material fluidizable y un segundo material fluidizable
ES2193395T3 (es) Procedimiento para mejorar la propiedad de retencion de aromas de envases de mezcla poliester/p0liamida para agua ozonizada.
ES2129157T3 (es) Maquina capsuladora de tipo con seguimiento lineal y procedimiento de capsulado de la misma.
AR030175A1 (es) Composiciones farmaceuticas en la forma de suspension, un recipiente que tiene un volumen de llenado y el uso de dicha composicion para la fabricacion de un medicamento
AR016843A1 (es) Dispositivo y procedimiento de descarga de un polvo de un recipiente a presion y reactor de polimerizacion con lecho fluidificado para ser usado con dicho dispositivo.
GB1316323A (en) Mixing vial
AR037160A1 (es) Un dispositivo no removible para vincular un dispositivo de administracion a un envase.

Legal Events

Date Code Title Description
FG Grant, registration